BR1100204A - Pharmaceutical composition to treat schizophrenia - Google Patents

Pharmaceutical composition to treat schizophrenia

Info

Publication number
BR1100204A
BR1100204A BR1100204-2A BR1100204A BR1100204A BR 1100204 A BR1100204 A BR 1100204A BR 1100204 A BR1100204 A BR 1100204A BR 1100204 A BR1100204 A BR 1100204A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
treat schizophrenia
schizophrenia
treat
pharmaceutical
Prior art date
Application number
BR1100204-2A
Other languages
Portuguese (pt)
Inventor
Yasuo Oshiro
Seiji Sato
Noboyuki Kurahashi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BR1100204-2A priority Critical patent/BR1100204A/en
Publication of BR1100204A publication Critical patent/BR1100204A/en

Links

BR1100204-2A 1988-10-31 1997-04-02 Pharmaceutical composition to treat schizophrenia BR1100204A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR1100204-2A BR1100204A (en) 1988-10-31 1997-04-02 Pharmaceutical composition to treat schizophrenia

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27695388 1988-10-31
BR1100204-2A BR1100204A (en) 1988-10-31 1997-04-02 Pharmaceutical composition to treat schizophrenia

Publications (1)

Publication Number Publication Date
BR1100204A true BR1100204A (en) 2000-08-01

Family

ID=25663526

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100204-2A BR1100204A (en) 1988-10-31 1997-04-02 Pharmaceutical composition to treat schizophrenia

Country Status (1)

Country Link
BR (1) BR1100204A (en)

Similar Documents

Publication Publication Date Title
SE8801813D0 (en) PHARMACEUTICAL COMPOSITION
KR890701101A (en) Pharmaceutical composition
BR8603566A (en) COMPOSITION FOR TISSUE TREATMENT
KR880005932A (en) Pharmaceutical composition for reducing neurotoxicity damage
FR2636532B1 (en) PHARMACEUTICAL COMPOSITIONS
DE122004000023I2 (en) Pharmaceutical composition
BR8905204A (en) COLUTORIA COMPOSITION
DK90089D0 (en) skin treatment composition
BR8901146A (en) PA TO HELICE CARENADA
BR8906787A (en) COMPOSITION
IT1209615B (en) PHARMACEUTICAL COMPOSITION
IT1217446B (en) OPHTHALMOLOGICAL COMPOSITION
MC1878A1 (en) PHARMACEUTICAL COMPOSITIONS
DK652687A (en) PHARMACEUTICAL COMPOSITION comprising AZUMOL
MX11584A (en) PHARMACEUTICAL COMPOSITIONS
BR8802235A (en) COMPOSITION FOR SULFUR DISSOLUTION
BR1100204A (en) Pharmaceutical composition to treat schizophrenia
IT8747977A0 (en) PHARMACEUTICAL COMPOSITIONS
KR920700539A (en) Anti-pollution treatment composition
IT1203737B (en) PHARMACEUTICAL COMPOSITIONS INCLUDING 3-AMINOPROPOSSI-INDOLI
IT1224244B (en) ANOREXIZING PHARMACEUTICAL COMPOSITION INCLUDING 5-IDROSSITRPOFANO
BR8900587A (en) COMPOSITION
BR8903660A (en) COMPOSITION FOR FABRIC TREATMENT
KR900002681A (en) Pharmaceutical composition with synergistic effect
SE8700576D0 (en) PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
MT Patent suspended - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96